Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| 1 |
Microsoft
MSFT
|
+$1.14B |
| 2 |
Uber
UBER
|
+$1.02B |
| 3 |
Apple
AAPL
|
+$906M |
| 4 |
Broadcom
AVGO
|
+$749M |
| 5 |
NVIDIA
NVDA
|
+$732M |
Top Sells
| 1 |
ATVI
Activision Blizzard Inc.
ATVI
|
+$1.52B |
| 2 |
Danaher
DHR
|
+$586M |
| 3 |
VMW
VMware, Inc
VMW
|
+$474M |
| 4 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$450M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$388M |
Sector Composition
| 1 | Technology | 28.87% |
| 2 | Financials | 12.76% |
| 3 | Healthcare | 12.47% |
| 4 | Consumer Discretionary | 11% |
| 5 | Industrials | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1826
Relay Therapeutics
RLAY
$688M
| $22.9M | ﹤0.01% |
2,081,510
+110,522
| +6% | +$1.22M |
|
1827
Energy Recovery
ERII
$764M
| $22.9M | ﹤0.01% |
1,216,051
+64,987
| +6% | +$1.22M |
|
1828
Chefs' Warehouse
CHEF
$2.7B
| $22.9M | ﹤0.01% |
777,377
+35,272
| +5% | +$1.04M |
|
1829
Pilgrim's Pride
PPC
$10.4B
| $22.8M | ﹤0.01% |
824,145
+11,594
| +1% | +$321K |
|
|
UMH
1830
UMH Properties
UMH
$1.29B
| $22.6M | ﹤0.01% |
1,477,710
+144,720
| +11% | +$2.22M |
|
1831
AvePoint
AVPT
$3.31B
| $22.6M | ﹤0.01% |
2,753,140
+65,915
| +2% | +$541K |
|
1832
Crescent Energy
CRGY
$2.21B
| $22.6M | ﹤0.01% |
1,709,707
+535,265
| +46% | +$7.07M |
|
1833
Preferred Bank
PFBC
$1.16B
| $22.5M | ﹤0.01% |
308,277
+636
| +0.2% | +$46.5K |
|
1834
RxSight
RXST
$381M
| $22.5M | ﹤0.01% |
558,507
+40,368
| +8% | +$1.63M |
|
1835
Enact Holdings
ACT
$5.74B
| $22.5M | ﹤0.01% |
779,404
+27,497
| +4% | +$794K |
|
1836
Collegium Pharmaceutical
COLL
$1.18B
| $22.5M | ﹤0.01% |
731,266
+20,382
| +3% | +$627K |
|
1837
Sweetgreen
SG
$1B
| $22.5M | ﹤0.01% |
1,989,688
+107,413
| +6% | +$1.21M |
|
1838
Kymera Therapeutics
KYMR
$3.36B
| $22.4M | ﹤0.01% |
880,515
+46,288
| +6% | +$1.18M |
|
1839
Cytek Biosciences
CTKB
$501M
| $22.4M | ﹤0.01% |
2,456,535
+102,083
| +4% | +$931K |
|
1840
PRA Group
PRAA
$657M
| $22.4M | ﹤0.01% |
854,181
+42,676
| +5% | +$1.12M |
|
1841
ADT
ADT
$7.24B
| $22.4M | ﹤0.01% |
3,279,115
+117,327
| +4% | +$800K |
|
1842
Vicor
VICR
$2.28B
| $22.3M | ﹤0.01% |
497,126
+12,523
| +3% | +$563K |
|
1843
Koppers
KOP
$567M
| $22.3M | ﹤0.01% |
435,703
+21,188
| +5% | +$1.09M |
|
1844
MiMedx Group
MDXG
$1.03B
| $22.3M | ﹤0.01% |
2,538,182
+109,838
| +5% | +$963K |
|
1845
Caleres
CAL
$503M
| $22.2M | ﹤0.01% |
723,493
+15,746
| +2% | +$484K |
|
1846
Avanos Medical
AVNS
$567M
| $22.2M | ﹤0.01% |
990,785
+43,039
| +5% | +$965K |
|
1847
Nicolet Bankshares
NIC
$2B
| $22.2M | ﹤0.01% |
275,512
+10,828
| +4% | +$872K |
|
1848
Monro
MNRO
$519M
| $22.1M | ﹤0.01% |
754,753
+34,248
| +5% | +$1M |
|
|
BDN
1849
Brandywine Realty Trust
BDN
$789M
| $22.1M | ﹤0.01% |
4,084,857
+145,153
| +4% | +$784K |
|
1850
Archer Aviation
ACHR
$5.64B
| $22M | ﹤0.01% |
3,590,599
+517,642
| +17% | +$3.18M |
|